Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial.
about
Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbsNew developments in the clinical use of drug-coated balloon catheters in peripheral arterial diseaseThe effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.Angiographic and Clinical Outcomes After Treatment of Femoro-Popliteal Lesions with a Novel Paclitaxel-Matrix-Coated Balloon Catheter.Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds.Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.An update on the clinical use of drug-coated balloons in percutaneous coronary interventions.Drug coated balloon angioplasty in the treatment of peripheral artery disease.Superficial Femoral Artery Intervention: Creating an Algorithmic Approach for the Use of Old and Novel (Endovascular) Technologies.[Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence].Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis.Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.Cost-effectiveness analysis of drug-coated therapies in the superficial femoral artery.Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal Stents in Symptomatic Patients With Femoropopliteal Disease.Debulking Plus Drug-Coated Balloon Combination as Revascularization Strategy for Complex Femoropopliteal Lesions: A New Standard Technique?Commentary: Next-Generation Drug-Coated Balloons: A New Era for Endovascular Therapy of the Femoropopliteal Arteries?Swirling Flow and Wall Shear: Evaluating the BioMimics 3D Helical Centerline Stent for the Femoropopliteal Segment.Real-world experience with a Paclitaxel-Coated Balloon for the treatment of atherosclerotic infrainguinal arteries: 12-month interim results of the BIOLUX P-III registry first year of enrolment.
P2860
Q26470510-9DA6A499-F830-48A3-80E0-E135A79CAD13Q26740218-EC365771-5204-4575-B3B3-6D02D04A6760Q30313782-A7E925D6-8D71-46EF-A2AB-409C56E7E288Q36354843-62965E88-45D3-412C-B09F-D48F7D0F4BF0Q36920052-518F8766-2CE2-48A7-AFD9-25662F60307AQ38374801-7BE172CB-A0E0-4A7B-8115-13B4D9CA85CDQ38376199-2B50E4F6-735D-4910-A98C-43586FCB24DCQ38378888-7BB41D44-1A3A-4C19-A071-F4D4F82E9DA6Q38560053-7CEF804D-CF01-4BD9-851A-F3F952591687Q38568152-9BAE1474-03D3-4077-90F4-78C4D8BF0CDFQ38715649-0006B4FB-9CC1-4CEA-BFB6-57F0A25ECA1BQ38754274-AD534895-78E6-48BB-9382-9272DD12C0FCQ38827478-295831C8-0FD5-4DFD-9CC6-C58F474B6C29Q38975104-D81CE2AF-2602-458D-8D79-9C2601779CFFQ40905783-A4D48380-1E16-4AF2-85B7-F643934AFDE1Q42428651-B2FE4D07-EED8-4007-ABE6-83C4547F3AE9Q47229750-91048A56-D6F1-4B0E-8415-0B7E7A830BBAQ47396762-B5960756-D794-4EEC-A0E2-FA8C37EEBB15Q47905623-44A545F1-D36F-4846-826E-B097B128C009Q48247913-5F08E898-092C-4883-8A22-B885380B481AQ50662064-0B50B343-9EC9-4078-801A-EE3E58D985F9Q50869166-869D0E0D-AB88-48C6-883A-BECFBC2701FCQ53261233-066D56EA-77C3-4EDB-BA07-131CE9144054Q55071098-A02966CA-F3DF-40CA-8614-AECC62C4C2D8Q55345329-36F670B4-F110-433C-900F-C278B277D25C
P2860
Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Paclitaxel-releasing balloon i ...... e BIOLUX P-I randomized trial.
@en
type
label
Paclitaxel-releasing balloon i ...... e BIOLUX P-I randomized trial.
@en
prefLabel
Paclitaxel-releasing balloon i ...... e BIOLUX P-I randomized trial.
@en
P2093
P2860
P356
P1476
Paclitaxel-releasing balloon i ...... e BIOLUX P-I randomized trial.
@en
P2093
Dierk Scheinert
Gunnar Tepe
Johannes Lammer
Karl-Ludwig Schulte
Thomas Zeller
P2860
P356
10.1177/1526602814564383
P577
2015-02-01T00:00:00Z